Questions for the Final FFICM Structured Oral Examination

Kate Flavin is an advanced trainee in Anaesthetics and Intensive Care Medicine in London. She has taken the MRCP, FRCA and FFICM and passed all components at the first attempt. Her experience as a senior trainee coupled with having recently sat the Final FFICM gives her a unique insight into the best approach to revision and what is required to achieve a pass. Clare Morkane is a dual Anaesthetic and Intensive Care Medicine registrar in London. Having recently undertaken the FFICM exams, she has a sound grasp of the syllabus and a real understanding of what it takes to pass. Sarah Marsh is a consultant in Anaesthesia and Intensive Care Medicine at Harrogate District Hospital, having obtained a Joint CCT in both disciplines in 2012. She has been involved in post-graduate education following the successful completion of the FRCA final exam in 2008, and is now the Course Director for the Faculty of Intensive Care Medicine's exam preparatory course and the Deputy National Lead for e-ICM.

• 1. Abdominal aortic aneurysm; 2. Abdominal compartment syndrome; 3. Acute ischaemic stroke; 4. Acute kidney injury and renal replacement therapy; 5. Acute liver failure and paracetamol overdose; 6. Acute respiratory distress syndrome; 7. Adrenal insufficiency in the ICU; 8. Amniotic fluid embolism; 9. Anaphylaxis; 10. Antibiotic therapy; 11. Antimicrobial resistance; 12. Aortic dissection; 13. Arrhythmias; 14. Asthma; 15. Bronchopleural fistulae; 16. Burns; 17. Calcium; 18. Cardiac output monitoring; 19. Cardiogenic shock; 20. Care of the heart-beating organ donor; 21. Chronic liver disease in the ICU; 22. Chronic obstructive pulmonary disease; 23. Colloids; 24. Critical incidents in the ICU; 25. Delirium; 26. Diabetic emergencies; 27. Diagnosing brainstem death; 28. Diarrhoea; 29. Disorders of consciousness; 30. Donation after circulatory death; 31. Drowning; 32. Encephalitis; 33. Fire in the ICU; 34. Fungal infection and antifungal therapy; 35. Guillian-Barré syndrome; 36. Haematological malignancy on the ICU; 37. Haemoglobinopathies, coagulopathies and thrombophilia on the ICU; 38. Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura; 39. High-risk surgical patient; 40. HIV in the ICU; 41. Hypertension; 42. Hyperthermia; 43. Hyponatraemia; 44. Hypothermia; 45. ICU-acquired weakness; 46. Infective endocarditis; 47. Inflammatory bowel disease and ICU; 48. Influenza; 49. Interstitial lung disease and critical care; 50. Intracerebral haemorrhage; 51. Magnesium; 52. Major incidents; 53. Malaria; 54. Mental capacity and deprivation of liberty; 55. Myasthenia gravis; 56. Necrotising fasciitis; 57. Non-invasive ventilation; 58. Nosocomial infection and ventilator-associated pneumonia; 59. Novel anticoagulants; 60. Nutrition in the ICU; 61. Percutaneous tracheostomy; 62. Pharmacokinetics in the critically ill patient; 63. Phosphate; 64. Plasmapheresis; 65. Pleural effusions; 66. Potassium; 67. Pre-eclampsia and HELLP; 68. Pseudo-obstruction and Ileus; 69. Puerperal sepsis; 70. Pulmonary haemorrhage and haemoptysis; 71. Pulmonary hypertension; 72. Rehabilitation following critical illness; 73. Rhabdomyolysis; 74. Right heart failure; 75. Scoring systems; 76. Sedation; 77. Sepsis; 78. Severe acute pancreatitis; 79. Spinal cord injury; 80. Subarachnoid haemorrhage; 81. Tetanus; 82. Thyroid emergencies; 83. Toxicology and overdose; 84. Transfusion; 85. Trauma; 86. Traumatic brain injury; 87. Tuberculosis; 88. Venous thromboembolism, heparin and heparin-induced thrombocytopenia; 89. Viral infection and antiviral therapy; 90. Weaning from mechanical ventilation; 91. Withdrawal of treatment and end-of-life care on the ICU.